Background. Current guidelines recommend counseling on risk-reduction strategies, including lifestyle modification, endocrine therapy, and bilateral mastectomy, for patients with classic-type lobular carcinoma in situ (LCIS) detected on core biopsy or surgical excision. Importantly, current diagnosis and treatment guidelines for classic-type LCIS do not include unilateral mastectomy for primary treatment or risk reduction. Prior studies reporting national practice patterns suggest increasing use of mastectomy for management of LCIS, with considerable variation by geographic region. However, these studies did not distinguish between uni-and bilateral mastectomies. This study aimed to investigate national practice patterns and factors associated with unilateral mastectomy. Methods. The study used the National Cancer Database to identify women with a diagnosis of LCIS from 2004 to 2013. Descriptive statistics were used to describe surgical treatment, and multinomial logistic regression was used to identify temporal, patient, and facility-level factors associated with receipt of uni-and bilateral mastectomy. Results. The study identified 30,105 women with LCIS. Of these woman, 5.4% received no surgery, 84.8% had surgical excision, 4% underwent unilateral mastectomy, and 5.1% underwent bilateral mastectomy. Adjusted analysis showed that young age, white race, insurance coverage, greater comorbidity, and geographic region (p \ 0.001) were associated with receipt of both uni-and bilateral mastectomy. Additionally, more recent year of diagnosis was associated with receipt of bilateral mastectomy. Unilateral mastectomy rates within geographic regions ranged from 2.7% in New England to 8% in the South. Conclusions. Nearly as many patients underwent unilateral (4%) as bilateral mastectomy (5.1%), representing inappropriate care. These findings highlight an opportunity to reduce unnecessary care through improved provider and patient education regarding optimal management of LCIS.
diagnosis was associated with receipt of bilateral mastectomy. Unilateral mastectomy rates within geographic regions ranged from 2.7% in New England to 8% in the South. Conclusions. Nearly as many patients underwent unilateral (4%) as bilateral mastectomy (5.1%), representing inappropriate care. These findings highlight an opportunity to reduce unnecessary care through improved provider and patient education regarding optimal management of LCIS.
With the growing use of screening mammography, the incidence of lobular carcinoma in situ (LCIS) has increased in recent years. 3 Commonly detected incidentally during needle biopsy for a separate indication, [4] [5] [6] [7] classic-type LCIS is not considered a precursor lesion. However, LCIS is accepted to be an indicator of increased risk for malignancy. Women with a diagnosis of LCIS have up to a 10-fold greater likelihood for the development of breast cancer than the general population. 8, 9 Current National Comprehensive Cancer Network (NCCN) guidelines recommend counseling on risk-reduction strategies to reduce lifetime risk of breast cancer for patients with classic-type LCIS detected on core biopsy or surgical excision. 10 Accepted approaches include lifestyle modification (exercise, weight control, and limiting of alcohol consumption), endocrine therapy, and bilateral mastectomy. 1 Importantly, current diagnosis and treatment guidelines for classic-type LCIS do not include unilateral mastectomy for primary treatment or risk reduction. 2 Although surgical excision is recommended for all patients with pleomorphic-type LCIS or LCIS that is non-concordant with imaging, further surgery for classic-type LCIS is not required if concomitant ductal carcinoma in situ or invasive carcinoma is not detected.
A prior study reporting national practice patterns suggests increasing use of mastectomy for management of LCIS, with considerable variation by geographic region. 3 However, this analysis did not distinguish between receipt of uni-and bilateral mastectomy, making it difficult to assess whether the use of mastectomy for women with LCIS is appropriate for risk reduction or represents inappropriate care.
The goal of the current investigation was to describe the surgical treatment of LCIS using a nationally representative data set and to identify patient and facility-level factors associated with unilateral mastectomy.
METHODS

Data Source and Cohort Selection
The National Cancer Data Base (NCDB) is a joint project of the Commission on Cancer of the American College of Surgeons and the American Cancer Society. It is a registry-based database that includes more than 70% of newly diagnosed cases in the United States and Puerto Rico. Trained registrars abstract data from the medical records at each of approximately 1400 facilities across the United States using a standardized abstraction manual.
11
Registrars are required to follow their patients from diagnosis until death regardless where they receive their follow-up care.
Women were included in our study if they had a new histologic diagnosis of LCIS from 2004 to 2013 (n = 44,646). We excluded men (n = 147). We also excluded women with a history of malignancy (n = 13,514), those who underwent surgery more than 120 days after the LCIS diagnosis (n = 565), and those for whom definitive surgical management was unknown (n = 315). The final sample size was 30,105 patients (Fig. 1 ).
Measures
Our primary outcome was the type of definitive surgery performed as part of first-course treatment. We categorized the NCDB-provided surgical procedure codes as follows: 1 (no surgery, code 00), 2 (surgical excision, codes [20] [21] [22] [23] [24] 12 We additionally evaluated whether patients underwent removal of lymph nodes, and whether they received endocrine therapy.
The patient demographics included year of diagnosis, age, race, insurance status, and Charlson Comorbidity Index. System-level factors included facility type and geographic region (West, Midwest, South, New England, and South Atlantic).
Statistical Analysis
We used descriptive statistics to summarize demographic characteristics and trends in the first course of surgical treatment for women with a diagnosis of LCIS during the study period. We assessed for differences in patient characteristics across the defined categories of definitive surgery using v 2 tests. A multinomial logistic regression model then was used to identify temporal, patient, and facility-level factors associated with receipt of unilateral mastectomy versus no surgery/surgical excision, and with bilateral mastectomy versus no surgery/surgical excision. Analyses were performed using Stata 12.1 (StataCorp, College Station, TX, USA).
This project is considered to be exempt by the University of Wisconsin Institutional Review Board.
RESULTS
Overall, women with LCIS had a median age of 52 years (range, 21-90 years). The majority of the women were white (85.5%), and 76.4% were privately insured. More than one third of the women received definitive treatment for their LCIS at an academic institution.
Of the total cohort, 5.4% did not receive surgery, 84.8% underwent surgical excision, 4% underwent unilateral mastectomy, and 5.1% underwent bilateral mastectomy as the definitive surgical treatment (Table 1) . Patients treated with surgical excision were unlikely to undergo lymph node examination (4%). However, 49% of the patients undergoing unilateral mastectomy and 44% of the patients undergoing bilateral mastectomy received lymph node examination. Overall, 24% of the women received endocrine therapy. This was most significantly more common (p \ 0.001) for the patients treated with surgical excision (25%) or no surgery (22%) than for the patients treated with mastectomy (13% of the unilateral and 6% of the bilateral procedures). Our multinomial analysis showed that patients were more likely to undergo either uni-or bilateral mastectomy (compared with no surgery or surgical excision) if they were younger, white, insured, or had greater comorbidity (p \ 0.01 for all) ( Table 2 ). The type of treatment facility was not significantly associated with whether patients received a mastectomy (p = 0.3), but geographic region of the reporting facility was a strong predictor of receipt of mastectomy (p \ 0.001) (Fig. 2) 
DISCUSSION
Using a large, nationally representative cohort of women with LCIS, we were able to demonstrate that the majority of women received appropriate surgical management, with the vast majority of women either receiving no surgery or undergoing surgical excision. Although a substantial proportion underwent mastectomy (9%), more than half of the mastectomies were bilateral procedures and therefore reflect an appropriate risk-reduction strategy for women with LCIS. However, a substantial proportion of women continue to undergo unilateral mastectomy (4%), with significant geographic variation. The rates ranged from 2.7% in New England to 8% in the South.
Our results are concordant with reported findings of Portschy et al. 3 and Wong et al. 13 each of whom used Surveillance, Epidemiology, and Results (SEER) data to examine rates of mastectomy (combined uni-or bilateral) for LCIS. The reported rates of mastectomy in these studies were 18% (Portschy et al. 3 in 2009) and 10.3% (Wong et al. 13 in 2013). Portschy et al. 3 also observed substantial variation in the receipt of mastectomy between geographic regions, with a low of 12% in Connecticut to a high of 24% in the Greater Georgia area. Similar to our results, these authors found young age and white race to be predictive of mastectomy. However, neither study distinguished between receipt of uni-and bilateral procedures.
For patients with LCIS, the NCCN guidelines advocate for counseling regarding risk-reduction strategies, with risk-reducing medical therapy as the preferred approach. 2 Yet, for patients who desire surgical treatment, prophylactic bilateral mastectomy may be considered for women with certain genetic mutations such as BRCA 1 or 2, a significant family history, or a history of prior thoracic radiation at age younger than 30 years. Institutional data suggest that these criteria apply to approximately 5% of patients with LCIS, 14 which is similar to the percentage of patients in our total cohort who received bilateral mastectomy.
Importantly, our results add to the existing literature by assessing trends in and predictors of bilateral procedures. In our cohort, the rising use of bilateral mastectomy in the management of patients with LCIS mirrors increasing rates of contralateral prophylactic mastectomy (CPM) among women with unilateral DCIS or early-stage invasive cancer in the United States. [15] [16] [17] [18] [19] [20] In the setting of malignancy, King et al. 15 reported that only 13% of patients who underwent CPM had documented evidence of being at high risk for contralateral breast cancer based on genetic mutations or history, suggesting that factors other than increased risk are driving the rise in bilateral mastectomy. Indeed, previous studies have identified an association between CPM, younger age, white race, and socioeconomic factors including higher education level, [17] [18] [19] 21 similar to the patient characteristics associated with receipt of a bilateral rather than a unilateral mastectomy in our cohort. Patient preference is believed to be a significant driver in the decision to pursue bilateral surgery for unilateral breast cancer 16, 22 and likely plays a key role in decision making for patients with LCIS as well. Rosenberg et al. 22 reported that emotional factors such as patient anxiety and perception that treatment decisions are patient driven rather than physician driven or shared were associated with CPM for women with early-stage breast cancer. 22 Although the long-term malignant potential of LCIS is poorly understood, the elevated risk for the development of breast cancer in patients with LCIS compared with the average population also may drive some patients to be proactive.
Recent work by King et al. 14 analyzing a prospectively maintained institutional database from 1980 to 2009 found the rate of cancer development in women with LCIS to be approximately 2% per year, equal to a cumulative rate of 26% at 15 years. This risk is the same for both breasts. A similar rate has been reported using SEER data, with a cumulative incidence of 11.3% at 10-years and 19.8% at 20 years. 13 These data offer valuable information for surgeons to incorporate when counseling patients with LCIS about their preferences, risk for future cancer, and potential benefits/risk associated with bilateral mastectomy.
A significant rate of LCIS upgrade to ductal carcinoma in situ or invasive cancer detected on core biopsy underlies current practice guidelines recommending surgical excision for pleomorphic LCIS or lesions nonconcordant with imaging. 23, 24 However, patients found to have either ductal carcinoma in situ or invasive cancer were excluded from our study and thus cannot explain the observed rate of unilateral mastectomy.
2 Adjusted analyses demonstrated striking geographic variation that cannot be easily explained. As such, these results suggest an opportunity to reduce unnecessary care through education at both a provider and patient level. Based on our findings, efforts to bolster provider knowledge are best targeted to specific geographic regions rather than types of facilities and should focus on specific vulnerable patient populations.
Although the NCDB advances prior investigation by offering analysis of a large, nationally representative cohort, it is not without limitation. In particular, the NCDB does not collect information regarding the patient's family history, prior radiation exposure, or genetic mutations such as BRCA 1 or 2. The NCDB also does not discriminate between pleomorphic and classic LCIS. The current guidelines do not necessitate excisional biopsy for all patients with classic-type LCIS shown on core biopsy, but do recommend surgical excision to negative margins for pleomorphic LCIS. However, the pleomorphic subtype represents a very small proportion of LCIS (\ 6%). 25 Furthermore, the use of unilateral mastectomy would represent overuse even in the setting of pleomorphic rather than classic-type LCIS. Finally, we do not have details of the imaging characteristics that may have led to selection of a specific treatment plan or provider-level data to assess variation based on practices of individual surgeons.
CONCLUSION
This population-based analysis demonstrated that nearly as many patients underwent unilateral (4%) as bilateral (5.1%) mastectomy, representing inappropriate care. These findings highlight an opportunity to reduce unnecessary care through improved provider and patient education regarding the natural history and optimal management of LCIS. 
